MDGL 241220 320.00P (MDGL241220P320000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

MDGL241220P320000

Watchlist

11.33
+1.63+16.80%

15min DelayClose Nov 29 13:00 ET

11.33High10.65Low

Intraday

5D
Daily

News

Analysts Are Bullish on Top Healthcare Stocks: Axsome Therapeutics (AXSM), Madrigal Pharmaceuticals (MDGL)
TipRanksNov 28 05:01 ET · Ratings
Express News | Form 144 | Madrigal Pharmaceuticals(MDGL.US) Director Proposes to Sell 3.23 Million in Common Stocks
Moomoo NewsNov 25 16:13 ET
Top 3 Health Care Stocks That May Dip This Month
BenzingaNov 25 08:29 ET
3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move
Yahoo FinanceNov 23 07:46 ET
Why Is Madrigal Pharmaceuticals, Inc. (MDGL) Among the Worst Performing Biotech Stocks in 2024?
Yahoo FinanceNov 21 17:12 ET
Novo Semaglutide Data in MASH Could Negatively Impact Madrigal's Rezdiffra
Seeking AlphaNov 20 14:02 ET

Comments

Stock_Drift

Nov 1 10:33

Unusual Volume Ticks. 11:32am

$Madrigal Pharmaceuticals (MDGL.US)$ $Nuburu (BURU.US)$ $Pro-Dex (PDEX.US)$ $ASP Isotopes (ASPI.US)$ $GRI Bio (GRI.US)$ $Vast Renewables (VSTE.US)$ $MicroCloud Hologram (HOLO.US)$ $Theriva Biologics (TOVX.US)$ $Pluribus Technologies Corp (PLRB.CA)$ $Ensysce Biosciences (ENSC.US)$ $Athira (ATHA.US)$ $Globalstar (GSAT.US)$ $ChromaDex (CDXC.US)$
📊⚡️📊

Jerry Kronenberg

Jun 11 14:52

Columns Madrigal Pharmaceuticals Rallies 15% on Wolfe Research 'Outperform' Rating

$Madrigal Pharmaceuticals (MDGL.US)$ rose some 15% Tuesday after Wolfe Research reportedly initiated coverage of the pharma firm with a "Outperform" rating.
MDGL gained as much as 15.2% to a $294.44 intraday high after Wolfe lauded the company's breakthrough liver drug Rezdiffra, according to published reports.
The U.S. Food and Drug Administration approved Rezdiffra in March as the first treatment fornonalcoholic steatoh...

Meltyy

May 16 01:29

🔔 Perceptive Advisors Q1 ‘24* Holdings Released... 🐳

» Holdings: 112
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
...

Meltyy

May 16 01:14

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...

Tao Lao Zoa

May 8 10:07

$Madrigal Pharmaceuticals (MDGL.US)$ Chi chif lao wai cheo? = They block Short why trade 😭😭😭😭😭